Kuhn Thomas, Wang Ying
Global Chemical Operations, Institutes for Biomedical Research, Novartis Pharma AG, Postfach, 4002 Basel, Switzerland.
Prog Drug Res. 2008;66:383, 385-422. doi: 10.1007/978-3-7643-8595-8_9.
Artemisinin-based Combination Therapies (ACT) are recommended by the World Health Organization (WHO) to treat especially multidrug resistant forms of malaria, as currently used medications have become increasingly ineffective. In this chapter, the discovery of artemisinin from Traditional Chinese Medicine and its further development to ACT are reviewed. It is highlighted how the complex supply chain to the naturally occurring endoperoxide artemisinin, required to produce ACT-based drugs, was established; thus addressing the significant therapeutic needs and high demands for the medication.
世界卫生组织(WHO)推荐以青蒿素为基础的联合疗法(ACT)来治疗尤其是耐多药形式的疟疾,因为目前使用的药物已变得越来越无效。在本章中,回顾了青蒿素从传统中药中的发现及其向ACT的进一步发展。重点介绍了如何建立生产基于ACT的药物所需的天然内过氧化物青蒿素的复杂供应链;从而满足了重大的治疗需求和对该药物的高需求。